Charles Conway, Chief Scientific Officer at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 4,000 shares at $72.15 ($289K) on 2020-06-17, disclosed to the SEC on 2021-03-05.
Open-market sale of $289k BHVN by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.